Résumé
Physostigmine, a centrally active anticholihesterase agent, was given to three patients with rigid Huntington’s disease (RHD). Neurologic examinations before, during and after the administration showed no change in the manifestations of RHD. The theoretical implications of these data are discussed.
| Langue d'origine | English |
|---|---|
| Pages (de-à) | 312-315 |
| Nombre de pages | 4 |
| Journal | Stereotactic and Functional Neurosurgery |
| Volume | 35 |
| Numéro de publication | 5 |
| DOI | |
| Statut de publication | Published - 1973 |
| Publié à l'externe | Oui |
ASJC Scopus Subject Areas
- Surgery
- Clinical Neurology